Eulav Asset Management Neogen Corp Transaction History

Eulav Asset Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$39.35 - $46.65 $928,660 - $1.1 Million	23,600 Added 11.99%	220,462 $9.78 Million
Q3 2021 Nov 15, 2021	BUY	$40.16 - $46.19 $2.54 Million - $2.93 Million	63,330 Added 47.43%	196,862 $8.55 Million
Q2 2021 Aug 06, 2021	BUY	$44.24 - $48.33 $3.37 Million - $3.69 Million	76,266 Added 133.18%	133,532 $6.15 Million
Q3 2020 Nov 05, 2020	BUY	$36.62 - $40.95 $183,100 - $204,750	5,000 Added 9.57%	57,266 $4.48 Million
Q1 2020 Apr 27, 2020	SELL	$27.01 - $36.38 $137,751 - $185,538	-5,100 Reduced 8.89%	52,266 $3.5 Million
Q4 2019 Feb 13, 2020	BUY	$31.33 - $34.86 $228,709 - $254,478	7,300 Added 14.58%	57,366 $3.74 Million
Q3 2019 Nov 12, 2019	BUY	$30.12 - $39.4 $331,320 - $433,400	11,000 Added 28.16%	50,066 $3.41 Million
Q1 2018 May 09, 2018	BUY	$27.32 - $33.49 $266,807 - $327,063	9,766 Added 33.33%	39,066 $2.62 Million
Q3 2017 Nov 14, 2017	BUY	$24.46 - $29.05 $19,568 - $23,240	800 Added 2.81%	29,300 $2.27 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,500	28,500 $1.97 Million

368

237M

181K

51.6K

Ticker NEOG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 216,108,000
Market Cap $2.6B
Description
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal f...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.